中州证券(01375.HK):常军胜辞任执行董事及总裁等职务
格隆汇6月9日丨中州证券(01375.HK)发布公告,董事会于2021年6月8日收到执行董事、副董事长及总裁常军胜先生提交的书面辞职报告,常军胜先生因个人家庭原因,申请辞去执行董事、副董事长、总裁、董事会发展战略委员会委员、董事会薪酬与提名委员会委员及其担任的公司其他一切职务。其辞职报告自送达董事会之日(即2021年6月8日)起生效。
董事会于同日召开的第六届董事会第三十一次会议审议通过了《关于常务副总裁代为履行总裁职责的议案》,同意由公司常务副总裁朱建民先生代为履行公司总裁职责,期限至公司新任总裁正式就任之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.